diclofenac has been researched along with Erythema in 14 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Erythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Diclofenac is a non-steroidal anti-inflammatory drug used for a variety of painful and inflammatory conditions." | 9.11 | Diclofenac systemic exposure is not increased when topical diclofenac is applied to ultraviolet-induced erythema. ( Kienzler, JL; Knops, A; Magnette, JL; Ménart, C; Nollevaux, F; Sallin, D, 2004) |
| "The efficacy and safety of aceclofenac (100 mg bid), a new nonsteroidal anti-inflammatory/anti-rheumatic agent, were compared with those of naproxen (500 mg bid) in a multi-centre, twelve-week, randomized, double-blind, parallel-group clinical trial in outpatients with active osteoarthritis of the knee." | 9.08 | Aceclofenac is a well-tolerated alternative to naproxen in the treatment of osteoarthritis. ( Bowdler, J; Frerick, H; Kornasoff, D; Montull, E, 1997) |
| " The rare but severe complications preclude further use of the intramuscular dosage in view of the availability of oral alternatives." | 5.30 | [Erythema and fever after diclofenac i.m]. ( Schaad, HJ; Zürcher, RM, 1998) |
| "Diclofenac is a non-steroidal anti-inflammatory drug used for a variety of painful and inflammatory conditions." | 5.11 | Diclofenac systemic exposure is not increased when topical diclofenac is applied to ultraviolet-induced erythema. ( Kienzler, JL; Knops, A; Magnette, JL; Ménart, C; Nollevaux, F; Sallin, D, 2004) |
| "The efficacy and safety of aceclofenac (100 mg bid), a new nonsteroidal anti-inflammatory/anti-rheumatic agent, were compared with those of naproxen (500 mg bid) in a multi-centre, twelve-week, randomized, double-blind, parallel-group clinical trial in outpatients with active osteoarthritis of the knee." | 5.08 | Aceclofenac is a well-tolerated alternative to naproxen in the treatment of osteoarthritis. ( Bowdler, J; Frerick, H; Kornasoff, D; Montull, E, 1997) |
| " The rare but severe complications preclude further use of the intramuscular dosage in view of the availability of oral alternatives." | 1.30 | [Erythema and fever after diclofenac i.m]. ( Schaad, HJ; Zürcher, RM, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (42.86) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takeda, K | 1 |
| Fujita, J | 1 |
| Fujii, T | 1 |
| Tanabe, H | 1 |
| Mochizuki, T | 1 |
| Yanagihara, M | 1 |
| Magnette, JL | 1 |
| Kienzler, JL | 1 |
| Sallin, D | 1 |
| Ménart, C | 1 |
| Nollevaux, F | 1 |
| Knops, A | 1 |
| Schleinitz, N | 1 |
| Veit, V | 1 |
| Coso, D | 1 |
| Aurran, T | 1 |
| Berbis, P | 1 |
| Harle, JR | 1 |
| Sarifakioglu, E | 1 |
| Nelson, CG | 2 |
| Spencer, J | 1 |
| Kantarci, G | 1 |
| Ozgüney, I | 1 |
| Karasulu, HY | 1 |
| Arzik, S | 1 |
| Güneri, T | 1 |
| Wahba-Yahav, AV | 1 |
| Zion, M | 1 |
| Kornasoff, D | 1 |
| Frerick, H | 1 |
| Bowdler, J | 1 |
| Montull, E | 1 |
| Rivers, JK | 1 |
| McLean, DI | 1 |
| Kido, H | 1 |
| Murakami, N | 1 |
| Ito, A | 1 |
| Kimura, K | 1 |
| Kodera, N | 1 |
| Doi, T | 1 |
| Naruse, T | 1 |
| Schaad, HJ | 1 |
| Zürcher, RM | 1 |
| del Pozo, MD | 1 |
| Lobera, T | 1 |
| Blasco, A | 1 |
| Bonina, FP | 1 |
| Puglia, C | 1 |
| Barbuzzi, T | 1 |
| de Caprariis, P | 1 |
| Palagiano, F | 1 |
| Rimoli, MG | 1 |
| Saija, A | 1 |
| Barrett, PJ | 1 |
| Fayle, R | 1 |
5 trials available for diclofenac and Erythema
| Article | Year |
|---|---|
Diclofenac systemic exposure is not increased when topical diclofenac is applied to ultraviolet-induced erythema.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Are | 2004 |
A single-arm, open-label efficacy and tolerability study of diclofenac sodium 3% gel for the treatment of actinic keratosis of the upper and lower lip.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; De | 2007 |
Comparison of different water/oil microemulsions containing diclofenac sodium: preparation, characterization, release rate, and skin irritation studies.
Topics: 1-Propanol; 2-Propanol; Administration, Cutaneous; Anti-Inflammatory Agents, Non-Steroidal; Cetomacr | 2007 |
Aceclofenac is a well-tolerated alternative to naproxen in the treatment of osteoarthritis.
Topics: Administration, Oral; Aged; Anti-Inflammatory Agents, Non-Steroidal; Chi-Square Distribution; Diclof | 1997 |
An open study to assess the efficacy and safety of topical 3% diclofenac in a 2.5% hyaluronic acid gel for the treatment of actinic keratoses.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Dermatitis, Irritant; Der | 1997 |
9 other studies available for diclofenac and Erythema
| Article | Year |
|---|---|
Case of remitting seronegative symmetrical synovitis with pitting edema (RS3PE syndrome) showing dermatomyositis-like eruption.
Topics: Aged; Antibodies, Antinuclear; Blood Sedimentation; C-Reactive Protein; Dermatomyositis; Diclofenac; | 2010 |
Drug-induced eosinophilia and systemic symptoms: hypersensitivity or peripheral T-cell lymphoma?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Cyclophosphamide; Diagnosis, | 2005 |
Nicolau syndrome after diclofenac injection.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Back Pain; Buttocks; Diclofenac; Erythema; Female; Humans; | 2007 |
Painful blotchy erythema: presentation of a case and successful control with diclofenac sodium.
Topics: Adult; Diclofenac; Erythema; Female; Humans; Recurrence | 1994 |
Anti-inflammatory, analgesic and anti-pyretic effects of d-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid (M-5011), a new non-steroidal anti-inflammatory drug, in rats and guinea pigs.
Topics: Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; | 1998 |
[Erythema and fever after diclofenac i.m].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Erythema; Fasciitis, Necrotizing; Female | 1998 |
Selective hypersensitivity to diclofenac.
Topics: Adult; Aged; Anaphylaxis; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Hypersensitivity | 2000 |
In vitro and in vivo evaluation of polyoxyethylene esters as dermal prodrugs of ketoprofen, naproxen and diclofenac.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Diclofe | 2001 |
Complications following intramuscular diclofenac.
Topics: Contusions; Diclofenac; Drug Eruptions; Erythema; Female; Humans; Middle Aged; Postoperative Complic | 1992 |